Titan Pharmaceuticals Stock Number Of Employees
| TTNP Stock | USD 3.96 0.32 8.79% |
Titan Pharmaceuticals fundamentals help investors to digest information that contributes to Titan Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Titan Stock. The fundamental analysis module provides a way to measure Titan Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Titan Pharmaceuticals stock.
Titan | Number Of Employees |
Titan Pharmaceuticals Company Number Of Employees Analysis
Titan Pharmaceuticals' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Titan Pharmaceuticals Number Of Employees | 4 |
Most of Titan Pharmaceuticals' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Titan Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Titan Number Of Employees Driver Correlations
Understanding the fundamental principles of building solid financial models for Titan Pharmaceuticals is extremely important. It helps to project a fair market value of Titan Stock properly, considering its historical fundamentals such as Number Of Employees. Since Titan Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Titan Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Titan Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Titan Pharmaceuticals is currently employing 4.0 people. This is 99.96% lower than that of the Pharmaceuticals sector and 99.25% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.98% higher than that of the company.
Titan Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Titan Pharmaceuticals' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Titan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Titan Pharmaceuticals by comparing valuation metrics of similar companies.Titan Pharmaceuticals is currently under evaluation in number of employees category among its peers.
Titan Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Titan Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Titan Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Titan Fundamentals
| Return On Equity | -3.69 | ||||
| Return On Asset | -1.73 | ||||
| Current Valuation | (2.8 M) | ||||
| Shares Outstanding | 914.23 K | ||||
| Shares Owned By Insiders | 45.46 % | ||||
| Shares Owned By Institutions | 1.85 % | ||||
| Number Of Shares Shorted | 8.71 K | ||||
| Price To Earning | (3.60) X | ||||
| Price To Book | 0.83 X | ||||
| Price To Sales | 1,208 X | ||||
| Revenue | 184 K | ||||
| Gross Profit | (4.37 M) | ||||
| EBITDA | (7.17 M) | ||||
| Net Income | (5.57 M) | ||||
| Cash And Equivalents | 6.42 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 565 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.06 X | ||||
| Book Value Per Share | 4.37 X | ||||
| Cash Flow From Operations | (7.09 M) | ||||
| Short Ratio | 1.04 X | ||||
| Earnings Per Share | (6.64) X | ||||
| Target Price | 7.0 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 3.34 M | ||||
| Total Asset | 8.09 M | ||||
| Retained Earnings | (391.83 M) | ||||
| Working Capital | 6.57 M | ||||
| Current Asset | 12.24 M | ||||
| Current Liabilities | 4.85 M | ||||
| Net Asset | 8.09 M |
About Titan Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Titan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Titan Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Titan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Titan Stock
| 0.89 | ETON | Eton Pharmaceuticals Downward Rally | PairCorr |
| 0.88 | VRNA | Verona Pharma PLC | PairCorr |
| 0.82 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.81 | ELDN | Eledon Pharmaceuticals | PairCorr |
| 0.46 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to Titan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Titan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Titan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Titan Pharmaceuticals to buy it.
The correlation of Titan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Titan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Titan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Titan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.